Only two liver abscesses were drained and cultured. In one patient with S. In the remaining patients, the cultures were discordant, because S. There was a patient with S. No statistically significant differences in outcomes were found between mitis and non-mitis VGS.
Only the S. One patient with S. All of the resistant strains were found in patients with hospitalization in the previous three months. Twenty-seven patients received antimicrobial treatment with vancomycin In four of these All of the strains were vancomycin-susceptible. Aetiology of bacteraemia as a risk factor for septic shock at the onset of febrile neutropaenia in adult cancer patients. BioMed Res Int.
While this may appear to be a low percentage, VGS bacteremia places patients with neutropenia at an increased risk for septic shock during a febrile neutropenic episode. In this series, overall mortality was VGS have been long recognized as difficult to identify at the species level using conventional microbiological techniques, and even with 16S rRNA sequencing. Streptococcus mitis strains causing severe clinical disease in cancer patients.
Emerg Infect Dis. This has prevented authors from reaching definitive conclusions on the relationship between species and clinical manifestations. It has been demonstrated to adequately identify S. J Med Microbiol. It can also misidentify S. In and , the rate of VGS in blood cultures was 0. Patients with hematological malignancies often have concurrent risk factors that predispose them to bloodstream infections by Gram-positive cocci. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Risk factors, such as mucositis due to chemotherapy, profound and prolonged neutropenia, increased use of long-term CVC, and antibiotic prophylaxis. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases. J Clin Microbiol. Given that VGS are part of the normal gastrointestinal and urogenital microbiome, it appears logical that gastrointestinal cancer group was next in frequency, followed by genital tract cancers.
There was only one patient with suspected endocarditis. It has been suggested that the low incidence of endocarditis in patients with hematological malignancies is due to low platelet counts. Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer.
Am J Infect Control. There are many different types of Streptococci and infections vary in severity from mild throat infections to pneumonia. Streptococcal infections are primarily treated with antibiotics. Many strains live naturally in humans causing no symptoms. Streptococcus pneumoniae S. It causes infections in both adults and children. It is transmitted through coughs and sneezes. Minor infections can be treated relatively easily with antibiotics and include: sinusitis inflammation of the sinuses middle ear infections.
More invasive infections pose a more serious threat to health and include: pneumonia inflammation of the tissue in the lungs meningitis inflammation of the membranes covering the brain and spinal cord bacteraemia infection of the blood.
People at the highest risk of invasive S. Streptococcus haemolyticus longus, pyogenes , which on blood-agar produces a clear zone of hemolysis about the colony; morphologically, it appears in chains of round or slightly oval cocci ; this is the type almost constantly found in erysipelas, complications of scarlet fever and various suppurative processes of streptococcus origin.
Arch Intern Med Chic. Coronavirus Resource Center. Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy Continue. Twitter Facebook. This Issue. A postmortem study of 3 patients who died after viridans streptococcal shock syndrome demonstrated 2 morphological phases [ 10 ]: an early phase, consisting of diffuse alveolar-interstitial damage characterized by congestion, alveolar-interstitial edema, hyperplasia of type II pneumocytes, sloughing of alveolar lining cells, and hyaline membrane formation, and a later phase, characterized by progressive interstitial and alveolar fibrosis.
Initial reports of viridans streptococcal bacteremia in patients with cancer and neutropenia revealed that these microorganisms were uniformly susceptible in vitro to penicillin. However, resistance of viridans streptococci to a number of antimicrobial agents has been increasingly recognized, and penicillin susceptibility can no longer be assumed.
In patients with cancer, neutropenia, and viridans streptococcal bacteremia, similar patterns of resistance have been reported table 3 [ 18 , 27 , 28 ]. In vitro resistance of viridans streptococci to vancomycin has not been reported. The fluoroquinolones, including the newer agents, are not sufficiently active against viridans streptococci to warrant use in treatment or prophylaxis.
Antimicrobial selection for treatment of viridans streptococcal infections must take into account the local in vitro pattern of antimicrobial susceptibility. Although this approach may successfully decrease the mortality associated with viridans streptococcal disease, the potential that infections caused by other resistant pathogens, such as vancomycin-resistant Enterococcus species, may be promoted must be carefully considered.
As always, each medical center should develop its own guidelines, but we believe that empirical therapy with vancomycin should be used only for those neutropenic patients with cancer who have shock or are developing ARDS. However, bacteremia may not always be the only factor leading to the patient's death. Because viridans streptococci are now an important emerging pathogen among patients with neutropenia, especially those who are undergoing bone marrow transplantation, some centers are using antimicrobial agents that have in vitro activity against these microorganisms to decrease colonization and, it is hoped, to prevent infection [ 3 , 4 ]; the agents used have included penicillin, ampicillin, vancomycin, and roxithromycin.
At one center, the incidence of streptococcal bacteremia was reduced from In another study, 22 8. Furthermore, those patients who received a fluoroquinolone and penicillin had an even higher rate of oropharyngeal colonization with viridans streptococci than did patients who received a fluoroquinolone alone.
These results contrast with those of another study, in which prophylactic use of ampicillin failed to decrease the incidence of viridans streptococcal sepsis among bone marrow transplant recipients [ 9 ]. Although the published data generally suggest that prophylactic administration of antimicrobial agents that have in vitro activity against the viridans streptococci reduces the incidence of significant infection, further development of resistance in viridans streptococci and other microorganisms is of great concern [ 18 , 28 ].
In addition, case-fatality rates may be higher among neutropenic patients with penicillin-resistant viridans streptococcal bacteremia than among those with infection caused by penicillin-susceptible strains [ 27 , 34 ]. Given the serious nature of septicemia caused by viridans streptococci and the potential for selection of resistant microorganisms including viridans streptococci, enterococci, and gram-negative bacilli that may cause significant disease and increased morbidity and mortality in neutropenic patients with cancer, we believe that the routine practice of using antimicrobial prophylaxis for this patient group should be reconsidered.
Google Scholar. Google Preview. Factors reported to predispose individuals to development of viridans streptococcal bacteremia. In vitro susceptibility of viridans streptococci isolated from neutropenic patients with cancer to selected antimicrobial agents. Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide.
Sign In or Create an Account. Sign In. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents Abstract.
Clinical Manifestations. Therapy and Outcome. Figures and Tables. Tunkel , Allan R. Reprints or correspondence: Dr. Tunkel, Dept. Oxford Academic. Kent A. Revision received:. Cite Cite Allan R. Select Format Select format.
0コメント